Concord Biotech

Global Tissue Transplant Market to Reach $198.72 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 20, 2022
General Health, Genetics, Health, Heart, Burn, Vein, Projection, Risk, Prevalence, Accident, Population, End organ damage, Diabetes, Patient, Cornea, Concord Biotech, Cancer, Burns, Transplant, Cell, Stryker, Cardiovascular disease, Method, Skin cancer, Tendon, Skin, Awareness, Kidney, Conditional sentence, Alzheimer's disease, CAGR, Dentistry

The "Global Tissue Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Tissue Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global tissue transplant market was evaluated at US$112.408 billion for the year 2020, growing at a CAGR of 8.48%, reaching the market size of US$198.728 billion by the year 2027.
  • Furthermore, the market is being driven by rising health awareness and government activities related to tissue donation.
  • However, the worldwide tissue transplant market's growth may be hampered by transplant rejection throughout the forecast period.

Global Oral Biologics & Biosimilar Drugs Markets, 2016-2021, 2021-2026F, 2031F: Lymphocyte Modulators, Interleukin Inhibitors, & Tumor Necrosis Factor-Alpha Inhibitors - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 17, 2022
Health, Pharmaceutical, Molecule, Diabetes, Disease, Food, Alzheimer's disease, Sarcoma, Government, Crohn's disease, Cell, Roche, EMA, Allergan, Monocyte, Immune system, Cancer, Prevalence, AstraZeneca, Novo Nordisk, Therapy, Cytokine, Multiple sclerosis, Insulin, HIV/AIDS, GlaxoSmithKline, Growth, Biosimilar, United Nations, Sanofi, US Foods, Eli Lilly and Company, Vaccine, Concord Biotech, Macrophage, Novartis, Arthritis, Carcinoma, European Medicines Agency, Distribution, Protein, Lundbeck, Multiple myeloma, Conditional sentence, Asthma, Psoriasis, Peptide, Technology, Lymphocyte, Enterocolitis, Interleukin, Pharmacy, Pharmaceutical industry, Generic drug, Dietary supplement, Food and Drug Administration Safety and Innovation Act

Oral Biologics & Biosimilar Drugs Implants Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics & biosimilars market.

Key Points: 
  • Oral Biologics & Biosimilar Drugs Implants Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics & biosimilars market.
  • The oral biologics and biosimilar market consist of sales of oral biologics and biosimilar products and related services used to treat chronic diseases such as diabetes, arthritis, cancer.
  • The oral biologics and biosimilar market comprise of biologics and biosimilar drugs taken orally for the targeted treatment of Alzheimer's, multiple sclerosis, HIV/AIDS and other serious conditions.
  • The main therapy types of are oral biologics and biosimilar lymphocyte modulators, interleukin inhibitors and tumor necrosis factor-alpha inhibitors.